Articles

Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;;KonKuk University Medical Center, KonKuk University School of Medicine, Seoul, Republic of Korea;
Center for International Blood & Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA;;Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA;
Dana-Farber Cancer Institute, Boston, MA, USA;
The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA;
Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia;
National Heart, Lung, and Blood Institute, Hematology Branch, National Institutes of Health, Bethesda, MD, USA;
Center for International Blood & Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA;
Dept of Pediatrics/Pediatrics Blood & Marrow Transplantation, Duke University Medical Center, Durham, NC, USA;
City of Hope National Medical Center, Duarte, CA, USA; and
Center for International Blood & Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA;
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;
Vol. 99 No. 12 (2014): December, 2014 https://doi.org/10.3324/haematol.2014.108977